Step by Step

INTRODUCTION

ABIM and DOB Data Collection

4/12/22 - Medical Grand Rounds: Colorectal Cancer Screening: Where We Are, and Where We May Be Going

QUIZ

EVALUATION

CERTIFICATE

INTRODUCTION

Credit Hours: CME 1.00

Target Audience:

Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.

Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Apply knowledge of current CRC screening options to improve patient outcomes
  • Engage in practice improvement to incorporate population-based approaches in CRC screening
  • For endoscopists, deploy available methods to audit colonoscopy quality and improve performance


Abstract

Dr. Uri Ladabaum, Professor of Medicine and Director of the Gastrointestinal Cancer Prevention Program at Stanford University School of Medicine, presentation for the Annual Sadie Gerson Distinguished Scholar Lecture, “Colorectal Cancer Screening:  Where We Are, and Where We May Be Going.

Suggested Additional Reading & Joint Accreditation Statement - Note: This Accreditation Statement Supersedes All Other Statements:

Joint Accreditation Statement

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit[s]™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This educational activity is approved for 1.0 contact hours.


Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Suggested Additional Reading:

  1. Atkin et al, Lancet 2010;375:1624
  2. Segnan et al, JNCI 2011;103:1310
  3. Schoen et al, NEJM 2012;366:2345
  4. Ladabaum et al, Gastro 2020;158:418
  5. Corley et al., NEJM 2014; 370:14
  6. Siegel et al., JNCI 2017;109(8)
  7. Repici et al., Gastro 2020; 159:512
  8. Huang et al., Int J Colorec Dis 2022; 37:495
  9. Ladabaum et al, Cancer Epidemiol Biomarkers Prev 2020;29:318

Authors:
Uri Ladabaum, MD, MS — Professor of Medicine, Senior Vice Chief
Director, Gastrointestinal Cancer Prevention Program
Division of Gastroenterology and Hepatology
Stanford University School of Medicine
Dr. Ladabaum is a Consultant for Freenome, Guardant, Medtronic, Leerink, ChekCap, and Clinical Genomics. No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

This activity is approved for AMA PRA Category 1 Credit™

The University of Pittsburgh is an affirmative action, equal opportunity institution.